Treatment and prevention of Pneumocystis infection in patients with HIV - UpToDate

{{configCtrl2.metaDescription()}}

Treatment and prevention of Pneumocystis infection in patients with HIV INTRODUCTION Pneumocystis jirovecii pneumonia (PJP) (formerly called Pneumocystis carinii pneumonia or PCP) is the most common opportunistic respiratory infection in patients with acquired immunodeficiency syndrome (AIDS). It typically occurs in patients with human immunodeficiency virus (HIV) with a CD4 count <200 cells/microL who are not receiving antiretroviral therapy or appropriate prophylaxis. This topic will review the treatment and prevention of PJP in patients with HIV infection. Topic reviews on the clinical…

related reading

• Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov
• Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy | Nature Reviews Neurologynature.com
• Overview of immune reconstitution inflammatory syndromesuptodate.com
• Interceptinterceptfund.com
• Table 1 Antifungal therapy in cryptococcal meningitis | Nature Reviews Neurologynature.com
• Acute Bronchitis - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• HIV-related lymphomas: Primary central nervous system lymphomauptodate.com
• HIV-related lymphomas: Primary central nervous system lymphomauptodate.com
• Exploring the barriers to the antiretroviral therapy adherence among people living with HIV in Bangladesh: A qualitative approachpmc.ncbi.nlm.nih.gov
• Pneumonia in children >28 days old: Inpatient treatmentuptodate.com
• Première rémission durable de l’infection par le VIH après greffe de moelle en l’absence de mutation protectrice | Pour chaque vie, la science agitpasteur.fr
• Pharmacological Management of Pediatric Pustular Psoriasis - PubMedpubmed.ncbi.nlm.nih.gov